Biocon Biologics Archives - Page 8 of 9 - Express Pharma

Biocon Biologics and Voluntis collaborate on digital therapeutics for insulins

Biocon Biologics gets DCGI approval for emergency use of CytoSorb to treat critical COVID-19 patients

EU GMP Certification for Biocon Biologics Drug Substance Facilities in Bengaluru

Biocon and Mylan Launch Fulphila, Biosimilar Pegfilgrastim, in Australia

Biocon gets three observations from US health regulator for Malaysia facility

Biocon sees revenue growth of 14 per cent to Rs 1,784 crores in Q3FY20

True North to invest Rs 536.25 cr in Biocon Biologics for 2.44 per cent stake

Biocon appoints Siddharth Mittal as its CEO and Joint MD

USFDA approves Biocon’s sBLA for Pegfilgrastim new manufacturing facility

Biocon features in the ASIA IP ELITE list for the fourth consecutive year